BioSpace News Archive

The global monocyte activation tests market was valued at approximately US$ 5.0 Mn in 2016 is projected to register cumulative annual growth rate of over 14.0% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Monocyte Activation Tests Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

The prevalence of behavioral health disorders has increased in the past few years, owing to which, TMR analysts hold a positive perspective of the market.

Pharmaceutical membranes are materials used in several medical processes along with associated filtration systems, mainly to act as selective barriers for certain substances to pass through them.

Cell proliferation regulation is a central part of the tissue morphogenesis process during the development of multicellular organisms.

“Pharma, Biotech and Medtech Half-Year Review 2020” analyses the market performance and deal landscape for the first half of 2020, focusing on the impact of COVID-19

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery Akoya, UCSF and the I-SPY TRIAL consortium collaborate to discover and validate biomarker signatures for predicting response to neoadjuvant and adjuvant immunotherapies MENLO PARK, Calif.--( BUSINESS WIRE )-- Akoya Biosciences, Inc., The Spatial Biology Company™, today announced a collaboration with UCSF Helen Diller Family Comprehe

Dosing of DNL758 (SAR443122) has commenced in a randomized, double-blind, placebo-controlled Phase 1b trial to evaluate safety and effect on the immune system in severe COVID-19 DNL758, discovered by Denali and partnered with Sanofi, is a small molecule inhibitor of RIPK1 that does not cross the blood-brain barrier, and is being developed for patients with peripheral inflammatory diseases

Device reduced disease activity in 50% of patients who had failed multiple drug classes including Janus Kinase Inhibitors (JAKi)